GSK (GSK) reported revenue of $10.60B in Q2 2026.
Register for a premium account to gain access to Sterling AI.
Get StartedThings you can ask Sterling:
GSK (GSK) reported revenue of $10.60B in Q2 2026.
Q3 2016-Q2 2026
Q3 2016-Q2 2026
GSKUK pharma with the largest dedicated vaccines P&L among the European names. FY 2025 vaccines £9.157B: Shingrix, meningitis, Arexvy (RSV), and established pediatric and flu lines.
GSK (GSK) is a Drug Manufacturers - General company. UK pharma with the largest dedicated vaccines P&L among the European names. FY 2025 vaccines £9.157B: Shingrix, meningitis, Arexvy (RSV), and established pediatric and flu lines. It was founded in 2000, is headquartered in London, UK and employs about 68,629 people.
Track GSK's quarterly and annual revenue, gross and net margins, and EPS in the interactive charts on this page. Data last updated August 19, 2026.
Sterling groups GSK in the Vaccines sector, alongside Pfizer (PFE), Merck & Co. (MRK) and Sanofi (SNY).
If you are researching GSK, also look at Pfizer (PFE), Merck & Co. (MRK) and Sanofi (SNY). You can compare all of them side by side or browse the full Vaccines sector on Sterling.